2 publications

• Published Subscription Original Research 25 Feb 2025

  Potential Risk and Benefits in Developing New Nanobot Technologies and Future Posibilities

  By K.Antony Ajitha, V.Sandhiya, D.Jeslin, S.Gowtham, R.Sundarajan, G.Vijiyamma, N.Deepa

  Abstract: The development of new nanobot technologies has the potential to revolutionize various fields, including medicine, manufacturing, and environmental science. However, as with any emerging technology, there are potential risks and benefits associated with nanobots. This abstract explores the potential risks, including toxicity, unintended consequences, and environmental impact, as well as the potential benefits, such as targeted drug delivery, diagnostic imaging, and tissue engineering. We also discuss the future possibilities of …

  Published in Research and Reviews: A Journal of Pharmaceutical Science · Vol. 16, Issue 1, 2025 · pp. 87–93 Read article →

• Published Subscription Review Article 30 Jan 2025

  Nanomedicine in Combination with Artificial Intelligence (AI): Transforming Cancer Treatment

  By D.Jeslin, G.Vijayamma, K.Antony Ajitha, S.Gowtham, N.Deepa, S.Nirmala, V.Harini

  Abstract: The convergence of nanomedicine and artificial intelligence (AI) holds transformative potential for advancing cancer treatment, particularly in liver cancer. Nanomedicine enables the development of targeted drug delivery systems, enhanced imaging modalities, and precise therapeutic interventions, while AI facilitates data-driven decision-making, personalized treatment plans, and predictive analytics. This synergistic approach can significantly improve the diagnosis, treatment, and monitoring of liver cancer by optimizing the use of nanoparticle-based therapies. AI-powered algorithms can …

  Published in Trends in Drug Delivery · Vol. 12, Issue 1, 2025 · pp. 27–30 Read article →